Salt Composition
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Pain relief / Treatment of Fever
Customers also bought
More About Zavipara 650 DT Tablet
Benefits
In Pain relief : Zavipara 650 DT Tablet is a common painkiller for treating aches and pains. It is widely used and rarely causes any side effects if taken properly. To get the most benefits, take it as prescribed. Do not take more or for longer than needed as that can be dangerous.In Treatment of Fever Zavipara 650 DT Tablet is also used to reduce a high temperature (fever). It works by blocking the release of certain chemical messengers that cause fever. It may be prescribed alone or in combination with other medicines. Take it as prescribed by the doctor.show moreshow less
Side Effects
Side effects of Zavipara Tablet DTThe majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Zavipara Stomach pain Nausea Vomiting
How to use
How to use Zavipara Tablet DTFollow your doctor's guidance regarding the dose and duration of this medication. Dissolve it in a glass of water before taking it. Zavipara 650 DT Tablet is to be taken with food.
How it works
How Zavipara Tablet DT works Zavipara 650 DT Tablet is an analgesic (pain reliever) and anti-pyretic (fever reducer). It works by blocking the release of certain chemical messengers that cause pain and fever.
Unsafe: Avoid consuming alcohol with Zavipara 650 DT Tablet as it is deemed unsafe.
Zavipara 650 DT Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Zavipara 650 DT Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Zavipara 650 DT Tablet does not usually affect your ability to drive.
Zavipara 650 DT Tablet should be used with caution in patients with kidney disease. Dose adjustment of Zavipara 650 DT Tablet may be needed. Doctor consultation is advised.However, Zavipara 650 DT Tablet contains paracetamol which is considered the safest painkiller for kidney disease patients.
Zavipara 650 DT Tablet should be used with caution in patients with liver disease. Dose adjustment of Zavipara 650 DT Tablet may be needed. Doctor consultation is advised.However, the use of Zavipara 650 DT Tablet is not recommended in patients with severe liver disease and active liver disease.
What if I forget to take it?
If a dose of Zavipara 650 DT Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
C01, Plot 50, Jp Road Versova, Andheri (W), Mumbai - 400061
References
Furst DE, Ulrich RW, Varkey-Altamirano C. Nonsteroidal Anti-Inflammatory Drugs, Disease Modifying Antirheumatic Drugs, Nonopioids Analgesics, & Drugs Used in Gout. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 635-36
Grosser T, Smyth E, FitzGerald GA. Anti-Inflammatory, Antipyretic, and Analgesic Agents; Pharmacotherapy of Gout. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 982-84
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 8-12
Paracetamol. County Tipperary, Ireland: Pinewood Healthcare; 2015 (17 Jun. 2019)
Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198 (02 Apr. 2019)
Central Drugs Standard Control Organisation (CDSCO) (02 Apr. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
